System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Domenico Girelli is an expert in Hematology at Azienda Ospedaliera Universitaria Integrata Verona (Italy). As of October 2026, ScienceLeadR ranks Domenico Girelli in the top 1% of experts worldwide for Iron Metabolism Disorders and Anemia. Domenico Girelli has authored 422 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 1,303 (community average: 125). How the SLR is computed.

LeadR Profile

Domenico Girelli Azienda Ospedaliera Universitaria Integrata Verona Italy
1 303 ScienceLeadR Reputation 1303

Unlock

Register Login
Network Map

Hematology

Subspecialties: Critical Care - Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026
Source: PubMed

University of Verona

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 422

Citations

Citations: 34 002 1st author: 42 Last author: 66 Unique author: 0

Main journals

Blood 46
Intern Emerg Med 23
Haematologica 19
Am J Hematol 11
Br J Haematol 9

Best Journals

N Engl J Med 4
Lancet 2
Nat Rev Endocrinol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Patient Blood Management in the Emergency Department: reducing transfusions and anemia-related admissions at 6 months.
PMID 42735064 — blood transfusion, blood, anemia, emergencies, emergency service, hospital, patient blood management		Blood Transfus20260
Evolution of Candidaemia and azole resistance in Italy: A multicentre retrospective study.
PMID 42678602 — epidemiology, retrospective studies, azoles, pandemics, intensive care units, communicable diseases, candida, infections		Eur J Clin Microbiol Infect Dis20260
Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE-related hemochromatosis.
PMID 42666846 — phlebotomy, hemochromatosis, therapeutics		Clin Hematol Int20261
Maternal and neonatal outcomes associated with haemoglobin concentration in pregnancy: a Burden of Proof study.
PMID 42559447 — hemoglobins, pregnancy, parturition, anemia		Nat Health20260
Rationale and design of the RISE-HF trial: sucrosomial iron in heart failure.
PMID 42502637 — exercise, quality of life, heart failure, heart, capsules, absorption		Int J Cardiol Heart Vasc20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 2 1
Phase 4 1

By status:

Recruiting 2
Unknown 2

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy and safety of vamifeport in adult subjects with HFE related hereditary hemochromatosis
2025-523793-16-00 — genes, safety, double-blind method, hemochromatosis, genes, regulator		Phase 2Recruiting2026
Management of Preoperative Anaemia in Surgical Oncology
NCT05505006 — injections, surgical oncology, blood transfusion, blood, anemia, vitamins, neoplasms, tablets, vitamin b 12, body weight, folic acid, therapeutics, patient blood management		Phase 4Recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS